Illumina and FlowJo Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

August 11, 2016 Leave a comment 2,874 Views

Software for analysis and reporting of single cell data will advance research into cell function, disease progression, and therapeutic response Illumina, Inc. (NASDAQ: ILMN) and FlowJo, LLC, today announced a partnership to develop and co-market analysis software for single cell ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: disease progression

Illumina and FlowJo Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

Tailoring the resolution of single-cell RNA sequencing for primary cytotoxic T cells

Upcoming Workshop – Bioinformatics Bootcamp Advanced Topics – Single Cell RNA-Seq

NDRindex – a method for the quality assessment of single-cell RNA-Seq preprocessing data

Study defines small-cell lung cancer subtypes and distinct therapeutic vulnerabilities for each type

Single-cell Multi-Omics: Marrying RNA Seq to protein expression and more

NASA GeneLab RNA-Seq Consensus Pipeline – Standardized Processing of Short-Read RNA-Seq Data

New approach emerges to better classify, treat brain tumors